Still no certainty about the role of upfront bortezomib among patients with AL amyloidosis

A. Dispenzieri

doi:10.1038/leu.2014.271

Still no certainty about the role of upfront bortezomib among patients with AL amyloidosis

A. Dispenzieri

Hematology

Research output: Contribution to journal › Editorial › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	2273-2275
Number of pages	3
Journal	Leukemia
Volume	28
Issue number	12
DOIs	https://doi.org/10.1038/leu.2014.271
State	Published - Dec 11 2014

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/leu.2014.271

Cite this

@article{101c12c16060466bbcb36a4ccc29b73d,

title = "Still no certainty about the role of upfront bortezomib among patients with AL amyloidosis",

author = "A. Dispenzieri",

year = "2014",

month = dec,

day = "11",

doi = "10.1038/leu.2014.271",

language = "English (US)",

volume = "28",

pages = "2273--2275",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - Still no certainty about the role of upfront bortezomib among patients with AL amyloidosis

AU - Dispenzieri, A.

PY - 2014/12/11

Y1 - 2014/12/11

UR - http://www.scopus.com/inward/record.url?scp=84925284470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925284470&partnerID=8YFLogxK

U2 - 10.1038/leu.2014.271

DO - 10.1038/leu.2014.271

M3 - Editorial

C2 - 25492370

AN - SCOPUS:84925284470

SN - 0887-6924

VL - 28

SP - 2273

EP - 2275

JO - Leukemia

JF - Leukemia

IS - 12

ER -

Still no certainty about the role of upfront bortezomib among patients with AL amyloidosis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this